Stock Offering

Esperion Stock Interest Strong, Underwriters’ Over-Allotment Option ExercisedEsperion Therapeutics Inc. (Nasdaq: ESPR), the Plymouth-based developer of new drugs to lower cholesterol levels in the blood, announced that the underwriters of its recently completed initial public offering have exercised in full their option to purchase an additional 750,000 shares of common stock from Esperion to cover over-allotments.
TRW Starts Secondary Stock OfferingTRW Automotive Holdings Corp. announced the underwritten public offering of 10 million shares of its common stock held by Automotive Investors L.L.C., an affiliate of The Blackstone Group L.P., and some company managers.
Adeona to Raise $3.5 Million In Stock OfferingAnn Arbor-based Adeona Pharmaceuticals Inc. said Thursday that it had an agreement for the sale of 1,688,782 shares of its common stock at $2.0725 per share to a new institutional investor in a registered direct offering for $3.5 million in gross proceeds